The chemokine receptor CXCR7 influences prognosis in human glioma in an IDH1-dependent manner

Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats

(2014) M J Walters et al.   BRITISH JOURNAL OF CANCER

Mutant IDH1 inhibits PI3K/Akt signaling in human glioma

(2014) Peter Birner et al.   CANCER

A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

(2014) Mark R. Gilbert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma

(2014) Olivier L. Chinot et al.   NEW ENGLAND JOURNAL OF MEDICINE

IDH mutation impairs histone demethylation and results in a block to cell differentiation

(2012) Chao Lu et al.   NATURE

The role of CXCR7 on the adhesion, proliferation and angiogenesis of endothelial progenitor cells

(2011) Xiaozhen Dai et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells

(2011) Brian A Zabel et al.   Molecular Cancer

Antiangiogenic therapy, hypoxia and metastasis: risky liaisons, or not?

(2011) Katrien De Bock et al.   Nature Reviews Clinical Oncology

CXCR4 and CXCR7 Have Distinct Functions in Regulating Interneuron Migration

(2011) Yanling Wang et al.   NEURON

Additive effect on survival of Raf kinase inhibitor protein and signal transducer and activator of transcription 3 in high-grade glioma

(2010) Judith Maresch et al.   CANCER

The Chemokine Receptor CXCR7 Is Highly Expressed in Human Glioma Cells and Mediates Antiapoptotic Effects

(2010) K. Hattermann et al.   CANCER RESEARCH

Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis

(2009) Marta Pàez-Ribes et al.   CANCER CELL

Antiangiogenic therapies for high-grade glioma

(2009) Andrew D. Norden et al.   Nature Reviews Neurology

Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1 

(2009) S. Zhao et al.   SCIENCE